Welcome to MutualFunds.com. Please help us personalize your experience.
Thank you for your submission, we hope you enjoy your experience

Select the one that best describes you
Mutualfunds logo

PHLAX Prudential Jennison Health Sciences A

  • Fund
  • PHLAX
  • Price as of: Aug 08, 2016
  • $38.77
  • - $0.48
  • - 1.22%
  • Category
  • Health & Biotech Equities

PHLAX - Profile

Vitals

  • YTD Return -11.1%
  • 3 Yr Annualized Return 13.0%
  • 5 Yr Annualized Return 19.3%
  • Net Assets $2.43 B
  • Holdings in Top 10 44.8%

52 WEEK LOW AND HIGH

$38.77
$32.78
$50.45

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.13%

SALES FEES

  • Front Load 5.50%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 52.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

Closed to new investors as of 2012-06-29

STANDARD (TAXABLE)

$2,500

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -11.1%
  • 3 Yr Annualized Total Return 10.9%
  • 5 Yr Annualized Total Return 18.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.67%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Prudential Jennison Health Sciences Fund
  • Fund Family Name Prudential Investments
  • Inception Date Jun 30, 1999
  • Shares Outstanding N/A
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager David Chan

Fund Description

The Prudential Jennison Health Sciences Fund Class A (PHLAX) is an actively managed fund that focuses on the health care sector of the world’s equity markets. PHLAX can own drug, health care, medicine, medical devices, and biotechnology stocks and can invest in any market-cap size. The fund uses various fundamental analyses to uncover the best growth stocks within the health care sector.

Even with its low costs, PHLAX’s focus on riskier segments of the equity markets makes the fund a satellite position only within a broader equity portfolio. The fund is managed by Jennison Associates LLC.

PHLAX - Performance

Return Ranking - Trailing

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -11.1% -25.2% 18.9% 83.04% 5
1 Yr -24.4% -29.1% 15.0% 83.04% 5
3 Yr 13.0% * 4.7% 22.2% 62.39% 4
5 Yr 19.3% * 10.5% 23.7% 35.24% 2
10 Yr 14.8% * 8.3% 16.3% 5.94% 1

* Annualized


Return Ranking - Calendar

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -8.5% -20.4% 13.8% 81.65% 5
2014 N/A 13.1% 21.8% N/A N/A
2013 N/A 30.6% 65.2% N/A N/A
2012 N/A 9.6% 27.7% N/A N/A
2011 N/A -1.8% 18.0% N/A N/A

Total Return Ranking - Trailing

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -11.1% -25.2% 18.9% 83.04% 5
1 Yr -28.6% -32.7% 15.0% 93.75% 5
3 Yr 10.9% * 3.2% 22.2% 74.31% 4
5 Yr 18.0% * 9.9% 23.7% 49.52% 3
10 Yr 14.1% * 8.0% 16.3% 10.89% 1

* Annualized


Total Return Ranking - Calendar

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -8.5% -20.4% 13.8% 81.65% 5
2014 N/A 17.6% 22.2% N/A N/A
2013 N/A 51.1% 71.1% N/A N/A
2012 N/A 19.8% 39.6% N/A N/A
2011 N/A 13.8% 20.1% N/A N/A

NAV & Total Return History

PHLAX - Holdings

Filings data as of: Jun 30, 2016

Concentration Analysis

PHLAX Category Low Category High PHLAX % Rank Quintile
Net Assets 2.43 B 23.8 M 50.7 B 12.50% 2
Number of Holdings 84 30 356 17.86% 3
Net Assets in Top 10 1.03 B 9.08 M 20.2 B 12.50% 2
Weighting of Top 10 44.8% 22.2% 68.4% 16.07% 2

Top 10 Holdings

  1. Biomarin Pharmaceutical Inc 5.92%
  2. Shire PLC ADR 4.64%
  3. Celgene Corp 5.68%
  4. Allergan PLC 4.74%
  5. Bristol-Myers Squibb Company 5.83%
  6. UnitedHealth Group Inc 4.55%
  7. Aetna Inc 4.04%
  8. Incyte Corp 3.11%
  9. Centene Corp 3.13%
  10. Eli Lilly and Co 3.13%

Asset Allocation

Weighting Category Low Category High PHLAX % Rank Quintile
Stocks
98.81% 87.51% 106.76% 12.50% 2
Other
0.69% -6.76% 2.31% 7.14% 2
Cash
0.50% 0.00% 12.50% 23.21% 4
Convertible Bonds
0.00% 0.00% 0.33% 3.57% 3
Preferred Stocks
0.00% 0.00% 1.48% 4.46% 3
Bonds
0.00% 0.00% 1.19% 3.57% 2

Stock Sector Breakdown

Weighting Category Low Category High PHLAX % Rank Quintile
Healthcare
98.46% 14.93% 99.47% 4.46% 1
Technology
0.35% 0.00% 64.47% 22.32% 4
Financial Services
0.00% 0.00% 1.13% 6.25% 3
Industrials
0.00% 0.00% 12.74% 15.18% 4
Utilities
0.00% 0.00% 1.25% 1.79% 2
Real Estate
0.00% 0.00% 1.99% 1.79% 2
Energy
0.00% 0.00% 0.00% 0.89% 2
Communication Services
0.00% 0.00% 2.23% 1.79% 3
Consumer Defense
0.00% 0.00% 2.38% 12.50% 3
Consumer Cyclical
0.00% 0.00% 4.23% 6.25% 3
Basic Materials
0.00% 0.00% 2.05% 3.57% 3

Stock Geographic Breakdown

Weighting Category Low Category High PHLAX % Rank Quintile
US
91.24% 62.67% 99.85% 11.61% 2
Non US
7.57% 0.14% 44.09% 18.75% 4

PHLAX - Expenses

Operational Fees

PHLAX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.13% 0.10% 4.31% 45.54% 2
Management Fee 0.71% 0.08% 1.25% 11.61% 3
12b-1 Fee 0.30% 0.00% 1.00% 7.69% 3
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

PHLAX Fees (% of AUM) Category Low Category High PHLAX Rank Quintile
Front Load 5.50% 3.50% 5.75% 7.69% 2
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

PHLAX Fees (% of AUM) Category Low Category High PHLAX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

PHLAX Fees (% of AUM) Category Low Category High PHLAX Rank Quintile
Turnover 52.00% 4.00% 249.00% 9.82% 4

PHLAX - Distributions

Dividend Yield Analysis

PHLAX Category Low Category High PHLAX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

PHLAX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

PHLAX Category Low Category High PHLAX % Rank Quintile
Net Income Ratio -0.67% -2.26% 1.24% 44.64% 3

Capital Gain Distribution Analysis

PHLAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

PHLAX - Managers

David Chan

Manager

Start Date

Jun 30, 1999

Tenure

17.1

Tenure Rank

1.8%

Managing director and portfolio manager of Jennison Associates LLC since 1999. He has a BA from Harvard University and an MBA from Columbia University. Mr. Chan generally has final authority over all aspects of the portfolio’s investments, including but not limited to, purchases and sales of individual securities, portfolio construction, risk assessment, and management of cash flows.


Michael A. Del Balso

Manager

Start Date

Oct 25, 2000

Tenure

15.78

Tenure Rank

3.1%

Michael Del Balso is a managing director, the director of research for growth equity, and a large cap growth equity portfolio manager. He joined Jennison Associates in May 1972 as a research analyst. He has been director of research for growth equity since 1994 and became a portfolio manager in 1999. Michael came to Jennison after four years with White, Weld & Company, where he was a vice president, stockholder and followed growth companies with emphasis on the consumer area. He received a BS in industrial administration from Yale University and an MBA from Columbia University.


Debra Netschert

Manager

Start Date

Jan 28, 2015

Tenure

1.51

Tenure Rank

18.9%

Debra Netschert is a Managing Director of Jennison. Ms. Netschert joined Jennison Associates in January 2008. Prior to Jennison, Ms. Netschert held health care research analyst positions at Magnetar Capital, Amaranth Capital, Lazard Capital Markets and UBS. She received her BS and MS from Boston University.


Tenure Analysis

Category Low

0.1

Category High

18.9

Category Average

8.99

Category Mode

1.6